$146/mo, locked in for life - no price increases with code YUCCA4LIFE.
- Up to $400 off + free shipping.
- Personalized tirzepatide & semaglutide plans.
- Prescription & telemed visits included — no insurance required.
Where to actually get a GLP-1 online — ten real services compared on the offers, pricing, and medication access each one publishes.
$146/mo, locked in for life - no price increases with code YUCCA4LIFE.
The Wellness Wire pick · July 22, 2026
$146/mo, locked in for life - no price increases with code YUCCA4LIFE.
Every service above carries a 1-to-10 editor’s score built from the five criteria below — our judgment, argued from public pricing pages, press releases, and the published trial data behind the medications they prescribe. There are no user votes, review counts, or stars anywhere on this page, because we didn’t collect any.
Which drugs the service can actually get you — brand-name access first, menu breadth second.
Each service’s own published offers and plans — membership plus medication — as of July 2026.
Licensed prescribers, dose titration, and who answers when the nausea hits in week two.
Published prices, clear terms — and how the service behaved during the compounding era.
The trial evidence behind what gets prescribed — brand-name GLP-1s over older or compounded options.
By trial evidence, tirzepatide (Zepbound). It produced the largest average loss of any approved drug in SURMOUNT-1 (20.9% at the top dose) and beat semaglutide directly in the SURMOUNT-5 head-to-head, 20.2% versus 13.7% at 72 weeks. Retatrutide posted bigger numbers in 2026 — up to 28.3% — but it is not approved yet.
The FDA labels set the same baseline for the drugs on this list: a body-mass index of 30 or higher, or 27 and up alongside at least one weight-related condition such as high blood pressure or type 2 diabetes — always combined with diet and activity changes. Whether a given drug fits your situation is a clinical decision made with a licensed prescriber.
The weight largely comes back. In the STEP 4 withdrawal trial, people switched from semaglutide to placebo regained 6.9% of body weight while those who stayed on lost a further 7.9% — a nearly 15-point swing. Researchers read this as obesity behaving like a chronic condition: the medications manage it, they don’t cure it.
Unevenly. Many employer plans still exclude weight-loss medications outright, which is why cash programs matter: LillyDirect sells Zepbound vials at $299–$449 a month and NovoCare sells Wegovy at $349. Federal pricing deals announced in late 2025 added a $350 tier via TrumpRx and a Medicare/Medicaid coverage pilot that has been rolling out in 2026. Check your specific plan — coverage rules change quarterly.
The membership pays for the clinical layer — prescriber visits, dose adjustments, messaging, coaching — while the drug itself bills separately at pharmacy prices. That’s why the manufacturer channels with no membership (LillyDirect, NovoCare) look cheaper: you bring your own prescriber. Bundled “medication included” plans exist, but check which drug and which dose the bundle actually covers.
Yes, through some services — with an important distinction. The mass-compounding era ended in 2025 once brand supply stabilized, but personalized doses prepared by licensed U.S. compounding pharmacies remain available, and several services on this list use that model. Compounded versions are not FDA-approved products and don’t go through the agency’s review of safety, efficacy, and manufacturing. Our explainer on compounded vs. brand-name GLP-1s covers the difference.